Vimarsana
Biggest News Aggregation in the World

Page 12 - Medication Errors News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Medication Errors. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Medication Errors Today - Breaking & Trending Today

Pfizer to Invest $120 Million to Produce COVID-19 Oral Treatment in the U.S. - Vimarsana News

Pfizer to Invest $120 Million to Produce COVID-19 Oral Treatment in the U.S.

Press release content from Business Wire. The AP news staff was not involved in its creation.

Source: apnews.com
At U.S. hospitals, a drug mix-up could be just a few keystrokes away - Vimarsana News

At U.S. hospitals, a drug mix-up could be just a few keystrokes away

There have been several incidents of hospital staffers searching computerized medication cabinets with three or fewer letters and then administering or nearly administering the wrong drug. Hospitals are not required to report most drug mix-ups.

Alkermes Presents New Data From Psychiatry Portfolio at 2022 Congress of the Schizophrenia International Research Society - Vimarsana News

Alkermes Presents New Data From Psychiatry Portfolio at 2022 Congress of the Schizophrenia International Research Society

/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today presented new research from its psychiatry portfolio at the 2022 Congress of the Schizophrenia International...

Alkermes plc: Alkermes Presents New Data From Psychiatry Portfolio at 2022 Congress of the Schizophrenia International Research Society - Vimarsana News

Alkermes plc: Alkermes Presents New Data From Psychiatry Portfolio at 2022 Congress of the Schizophrenia International Research Society

- Detailed Results Presented From ENLIGHTEN-Early Phase 3b Study of LYBALVI in Patients Early in Illness - DUBLIN, April 7, 2022 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today presented

Pfizer to Supply UNICEF up to 4 Million Treatment Courses of Novel COVID-19 Oral Treatment for Low- and Middle-Income Countries - Vimarsana News

Pfizer to Supply UNICEF up to 4 Million Treatment Courses of Novel COVID-19 Oral Treatment for Low- and Middle-Income Countries

22.03.2022 - Pfizer Inc. (NYSE: PFE) announced today an agreement with UNICEF to supply up to 4 million treatment courses of its COVID-19 oral treatment, PAXLOVID (nirmatrelvir [PF-07321332] tablets and ritonavir tablets), to 95 low- and middle-income countries, ...